Adiponectin has protective effects against endometrial, prostate, thyroid, and ovarian tumors (126, 127), and lower adiponectin concentrations linked to excess adipose tissue in the body can inhibit this protective function in obese patients. Here, ADIPOQ is linked to ovarian neoplasm.